Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Total Current Liabilities (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Total Current Liabilities for 17 consecutive years, with $456.0 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 50.55% to $456.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $456.0 million through Dec 2025, down 50.55% year-over-year, with the annual reading at $456.0 million for FY2025, 50.55% down from the prior year.
  • Total Current Liabilities hit $456.0 million in Q4 2025 for Integra Lifesciences Holdings, up from $364.1 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $929.8 million in Q2 2025 to a low of $282.3 million in Q1 2023.
  • Historically, Total Current Liabilities has averaged $454.8 million across 5 years, with a median of $336.4 million in 2021.
  • Biggest YoY gain for Total Current Liabilities was 203.73% in 2025; the steepest drop was 60.11% in 2025.
  • Year by year, Total Current Liabilities stood at $340.0 million in 2021, then fell by 5.62% to $320.9 million in 2022, then decreased by 4.34% to $307.0 million in 2023, then surged by 200.39% to $922.1 million in 2024, then tumbled by 50.55% to $456.0 million in 2025.
  • Business Quant data shows Total Current Liabilities for IART at $456.0 million in Q4 2025, $364.1 million in Q3 2025, and $929.8 million in Q2 2025.